As of 2024-07-27, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is (7.15) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.79 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -1004.8%.
The range of the Relative Valuation is (6.19) - (7.86) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.3x - 2.0x | 1.6x |
| Forward P/E multiples | 1.6x - 2.3x | 2.0x |
| Fair Price | (6.19) - (7.86) | (7.15) |
| Upside | -884.2% - -1095.3% | -1004.8% |
| Date | P/E |
| 2024-07-26 | -0.27 |
| 2024-07-25 | -0.27 |
| 2024-07-24 | -0.28 |
| 2024-07-23 | -0.30 |
| 2024-07-22 | -0.31 |
| 2024-07-19 | -0.31 |
| 2024-07-18 | -0.30 |
| 2024-07-17 | -0.31 |
| 2024-07-16 | -0.32 |
| 2024-07-15 | -0.34 |
| 2024-07-12 | -0.32 |
| 2024-07-11 | -0.34 |
| 2024-07-10 | -0.35 |
| 2024-07-09 | -0.35 |
| 2024-07-08 | -0.36 |
| 2024-07-05 | -0.36 |
| 2024-07-04 | -0.38 |
| 2024-07-03 | -0.35 |
| 2024-07-02 | -0.36 |
| 2024-06-28 | -0.35 |
| 2024-06-27 | -0.36 |
| 2024-06-26 | -0.35 |
| 2024-06-25 | -0.35 |
| 2024-06-24 | -0.36 |
| 2024-06-21 | -0.36 |
| 2024-06-20 | -0.39 |
| 2024-06-19 | -0.42 |
| 2024-06-18 | -0.41 |
| 2024-06-17 | -0.42 |
| 2024-06-14 | -0.43 |
| 2024-06-13 | -0.47 |
| 2024-06-12 | -0.42 |
| 2024-06-11 | -0.43 |
| 2024-06-10 | -0.43 |
| 2024-06-07 | -0.44 |
| 2024-06-06 | -0.45 |
| 2024-06-05 | -0.46 |
| 2024-06-04 | -0.44 |
| 2024-06-03 | -0.46 |
| 2024-05-31 | -0.46 |
| 2024-05-30 | -0.53 |
| 2024-05-29 | -0.55 |
| 2024-05-28 | -0.54 |
| 2024-05-27 | -0.56 |
| 2024-05-24 | -0.54 |
| 2024-05-23 | -0.51 |
| 2024-05-22 | -0.54 |
| 2024-05-21 | -0.55 |
| 2024-05-17 | -0.56 |
| 2024-05-16 | -0.56 |